Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 56.0 | 56 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 40.0 | 62 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 42.0 | 63 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 51.0 | 61 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 45.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 44.0 | 45 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 51.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 39.5 | 56 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 35.0 | 61 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 54.0 | 49 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | IL18 | 61.5 | 42 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 34.0 | 39 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 33.0 | 47 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 30.0 | 46 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 23.0 | 72 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 27.0 | 83 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 23.0 | 47 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 32.0 | 61 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 25.0 | 39 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 26.0 | 50 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 33.0 | 44 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 23.0 | 44 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | IL18 | 27.0 | 37 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL18 | 32.0 | 48 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | IL18 | 30.0 | 53 |